Daniel Hurren's questions to Resmed Inc (RMD) leadership • Q1 2025
Question
Daniel Hurren inquired about ResMed's M&A priorities, the potential scale of "tuck-in" acquisitions given its debt capacity, and the overall capital management strategy.
Answer
CEO Michael Farrell highlighted successful tuck-ins like Snap and Somnoware that add digital capabilities. CFO Brett Sandercock defined "tuck-in" as potentially up to $500 million and outlined the capital priorities as R&D investment, tuck-in M&A, and an increasing quarterly share buyback program.